MindBio Therapeutics Expands AI Voice Analytics Platform to Detect Fatigue in High-Risk Workplaces

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is extending the capabilities of its artificial intelligence-powered voice analytics platform to include fatigue detection, a move that could offer a scalable, non-invasive alternative to traditional impairment screening methods in high-risk workplace environments. The company, which specializes in commercializing AI voice technology for drug and alcohol intoxication detection, announced the development of a fatigue prediction model designed for sectors such as mining, aviation, construction, and law enforcement.

According to a recent article highlighting MindBio’s progress, the fatigue detection capability is expected to become an additional feature within the company’s planned Edge AI Intoxication Detection Kiosks. These kiosks are being designed to identify signs of alcohol, drug impairment, and fatigue from short voice samples. The announcement reflects a broader strategy by MindBio to position voice analytics as a scalable alternative to conventional impairment screening methods such as breathalyzers, saliva tests, urine analysis, and laboratory-based toxicology testing.

Rather than relying on physical samples, MindBio’s platform analyzes speech characteristics captured through a microphone and processes the audio using machine learning models trained on large voice datasets. The company’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The expansion into fatigue detection leverages similar voice analysis principles, potentially allowing employers to screen workers for impairment without the need for invasive or time-consuming sample collection.

The implications for workplace safety are significant. Industries such as mining and construction, where fatigue is a known risk factor for accidents, could benefit from real-time, non-invasive monitoring. Similarly, aviation and law enforcement agencies could use the technology to ensure personnel are fit for duty. By integrating fatigue detection into the same kiosks used for intoxication screening, MindBio aims to offer a comprehensive impairment detection solution that addresses multiple risk factors simultaneously.

MindBio is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI. The company’s technology is being positioned for a range of enterprise environments, with the fatigue prediction model representing the latest step in its evolution.

For more information on MindBio Therapeutics and its latest developments, visit the company’s newsroom at https://ibn.fm/MBQIF. The full article detailing the expansion into fatigue detection is available at https://ibn.fm/UiSYI.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MindBio Therapeutics Expands AI Voice Analytics Platform to Detect Fatigue in High-Risk Workplaces.

The post MindBio Therapeutics Expands AI Voice Analytics Platform to Detect Fatigue in High-Risk Workplaces appeared first on citybuzz.